RxDoctor Payments DataLook up a doctor →

Orladeyo: payments to doctors

Payments that named Orladeyo as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$3.1M
Providers
4,431
Transactions
27,861
Average per transaction
$112

The per-transaction average — $112 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,431 providers the average total is $702, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Biocryst US Sales Co., LLC$2,782,81889.4%
Biocryst Pharmaceuticals, Inc.$329,09910.6%
← All drugs & devices